Mediland Stem Cell Therapy Center is one of the oldest and most experienced regenerative medicine clinics in Europe, with a history deeply connected to the scientific development of cellular therapy and translational biotechnology. Our work combines advanced stem cell therapy, exosome technologies, regenerative protocols, anti-aging medicine, biobanking, and personalized cellular treatment programs developed over decades of clinical and laboratory practice.
The foundation of our clinical and scientific activity began in the 1970s, when a group of researchers at the National Medical University initiated experimental studies on the regenerative potential of stem cells in animal models. These early studies demonstrated the positive influence of fetal-derived cellular material on neuro dystrophic and degenerative processes in damaged tissues and organs. Based on these findings, our founders continued scientific development and later translated these technologies into clinical medicine.
By 1987, our specialists became among the first physicians in the world to clinically apply stem cell therapy for severe hematological disorders, including cytostatic myelo depression and aplastic anemia. These pioneering treatments marked the beginning of a new era in regenerative and cellular medicine.
More Than 24 Years of Clinical Experience in Cellular Therapy
Following official approval from the Ministry of Health of Ukraine in 2002, stem cell therapies at Mediland Stem Cell Therapy Center began to expand into multiple medical fields. Cellular technologies were gradually introduced for degenerative, autoimmune, neurological, metabolic, vascular, and chronic inflammatory conditions.
During this period, our scientific team developed proprietary protocols for stem cell harvesting, cryopreservation, preparation of cell suspensions, and clinical transplantation. These methods demonstrated encouraging therapeutic outcomes while maintaining a strong safety profile.
Our clinic became one of the first centers globally to develop original stem cell treatment protocols for conditions such as:
- Multiple sclerosis
- Diabetes mellitus
- Autism spectrum disorders
- Neurodegenerative diseases
- Immune-related disorders
- Tissue degeneration syndromes
In 2004, based on extensive clinical experience and scientific advancement, our team established one of the world’s first specialized stem cell therapy centers in Kyiv, Ukraine.
Today, Mediland Stem Cell Therapy Center has performed more than 9,400 stem cell transplantations for patients from over 93 countries worldwide.
International Recognition and Scientific Contribution
Over decades of intensive scientific work, Mediland Stem Cell Therapy Center has gained international recognition in the fields of regenerative medicine, stem cell biotechnology, exosome therapy, and translational research.
Our physicians and researchers have authored more than 300 scientific publications published in national and international journals, congress proceedings, and medical conferences. Our work focuses on:
- Stem cell biology
- Cellular transplantation
- Exosome and extracellular vesicle therapy
- Regenerative neurology
- Immunomodulation
- Anti-aging medicine
- Tissue engineering
- Cellular metabolism and mitochondrial medicine
Our scientific and clinical developments continue to evolve through collaboration with physicians, biotechnology experts, and research institutions across Europe.
Patented Stem Cell Technologies and Intellectual Property
All major stem cell treatment methods used at SmartCell Center are protected by international patents and intellectual property rights.
Our first patent application related to the clinical use of stem cell suspensions dates back to October 18, 2003, making our center one of the earliest institutions worldwide to patent practical clinical applications of cellular therapy.
Our patents include technologies related to:
- Hematopoietic stem cell harvesting
- Cell suspension manufacturing
- Cryopreservation systems
- Multiple sclerosis treatment
- Autism therapy protocols
- Diabetes regenerative protocols
- Psoriasis treatment
- Oncology-supportive cellular technologies
- Aplastic anemia treatment
This extensive intellectual property portfolio reflects decades of original scientific development and clinical innovation. Discover more about our Center : Stem Cell Treatment Abroad: An International Clinic with Advanced Regenerative Medicine Solutions
Advanced Clinical and Laboratory Infrastructure
Today, SmartCell Center includes a modern clinical department and a highly specialized laboratory complex operating within its own advanced biotechnology facility.
Our clinic combines diagnostics, regenerative medicine, cellular therapy, anti-aging medicine, and laboratory biotechnology under one integrated medical system.
Clinical Department
Our clinical department includes physicians with extensive experience in regenerative medicine, endocrinology, neurology, immunology, rehabilitation medicine, and anti-aging therapies.
The clinic provides advanced diagnostics and patient monitoring, including:
- Ultrasound diagnostics
- ECG and EchoCG
- Doppler studies
- Functional diagnostics
- Laboratory monitoring
- Personalized consultation programs
Every regenerative treatment protocol is individualized according to the patient’s medical history, laboratory profile, disease stage, and biological condition.
Biotechnology Laboratory and Cell Manufacturing
Our Biotechnology Laboratory is responsible for the preparation, quality control, cultivation, and cryopreservation of stem cell suspensions and regenerative biologics.
The production process includes:
- Ethical and controlled donor material collection
- Preparation of sterile stem cell suspensions
- Viability and safety testing
- Programmed cryopreservation
- Long-term cryostorage
- Quality monitoring and batch control
The integration of laboratory production and clinical transplantation within one medical ecosystem allows maximal quality control and preservation of biological activity.
PCR Laboratory and Biosafety Control
Safety remains one of the core priorities of SmartCell Center.
Our PCR Laboratory performs advanced molecular screening and biosafety testing for cellular products and biologic materials. Stem cell suspensions undergo real-time PCR testing for infectious agents including:
- HIV-1/2
- HBV
- HCV
- CMV
- HSV-1/2
- Treponema pallidum
- Chlamydia trachomatis
- Mycoplasma species
- Ureaplasma species
Additional sterility and microbiological controls are performed according to international biosafety standards.
Cryobank and Long-Term Cell Preservation
Our cryobank contains more than 10,000,000 individual samples of stem cell suspensions and regenerative biologics.
Using advanced programmed freezing technologies and controlled cryostorage systems, we preserve cellular viability, biological activity, and long-term therapeutic potential.
The cryobank serves as a critical component of our regenerative medicine platform, allowing long-term storage and future therapeutic use of biological materials.
Expansion Across Europe
Since 2024, SmartCell Center has expanded through partner departments and collaborative regenerative medicine programs in:
- Poland
- Ukraine
- Austria ( LAB)
- Bulgaria
Our biotechnology products — including stem cells, exosomes, placenta-derived extracts, growth factors, peptide therapies, and BHRT solutions — are delivered internationally under strict quality and biosafety protocols.
This international expansion allows patients across Europe to access advanced regenerative therapies supported by centralized laboratory quality control and standardized biotechnology production.
Regenerative Medicine, Exosomes, BHRT and Anti-Aging Programs
Beyond classical stem cell therapy, Mediland Stem Cell Therapy Center actively develops comprehensive regenerative medicine protocols integrating:
- Mesenchymal stem cells
- Exosome therapy
- Placenta-derived biologics
- IPCS cells
- Neural cells
- Growth factors
- Peptide therapy
- Bioidentical hormone replacement therapy (BHRT)
- Mitochondrial support programs
- Anti-aging medicine
- Cellular detoxification protocols
- Neuroregenerative technologies
Our multidisciplinary approach focuses on restoring cellular function, improving tissue regeneration, supporting metabolic balance, reducing inflammation, and optimizing biological aging processes. More information about our biobank products:Advanced Regenerative Medicine Technologies and Cellular Laboratory Solutions at Mediland Stem Cell Therapy Center
Commitment to Innovation, Safety and Personalized Medicine
At Mediland Stem Cell Therapy Center , continuous scientific advancement remains one of our core principles. Our specialists actively work on improving stem cell preparation methods, exosome technologies, regenerative protocols, and personalized treatment systems.
We continuously invest in:
- Laboratory modernization
- Biosafety systems
- Cell characterization technologies
- Flow cytometry
- Cellular culturing methods
- Cryopreservation technologies
- Translational regenerative research
Our mission is to provide scientifically grounded, safe, and individualized regenerative therapies for patients worldwide.
For us, the greatest achievement is not only scientific recognition, patents, or international expansion — but the clinical improvements, restored quality of life, and trust of our patients.